Merck (UK) Performance
| 0QAH Stock | USD 99.10 1.20 1.20% |
The company secures a Beta (Market Risk) of 1.3, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Merck will likely underperform. Merck Company right now secures a risk of 4.65%. Please verify Merck Company treynor ratio, value at risk, and the relationship between the total risk alpha and maximum drawdown , to decide if Merck Company will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent essential indicators, Merck is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Forward Dividend Yield 0.0283 | Payout Ratio 0.6535 | Forward Dividend Rate 2.92 | Ex Dividend Date 2023-09-14 |
1 | Merck Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch | 11/19/2024 |
2 | Eagle Rock Investment Company LLC Sells 13,523 Shares of Merck Co., Inc. - MarketBeat | 01/17/2025 |
| Begin Period Cash Flow | 12.8 B | |
| Free Cash Flow | 9.1 B |
Merck |
Merck Relative Risk vs. Return Landscape
If you would invest 10,577 in Merck Company on October 22, 2024 and sell it today you would lose (667.00) from holding Merck Company or give up 6.31% of portfolio value over 90 days. Merck Company is generating 0.0029% of daily returns and assumes 4.6472% volatility on return distribution over the 90 days horizon. Simply put, 41% of stocks are less volatile than Merck, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Merck Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Merck's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Merck Company, and traders can use it to determine the average amount a Merck's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 6.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0QAH |
Estimated Market Risk
| 4.65 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Merck is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merck by adding Merck to a well-diversified portfolio.
Merck Fundamentals Growth
Merck Stock prices reflect investors' perceptions of the future prospects and financial health of Merck, and Merck fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Merck Stock performance.
| Return On Equity | 0.0761 | ||||
| Return On Asset | 0.0512 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 271.24 B | ||||
| Shares Outstanding | 2.54 B | ||||
| Price To Book | 5.63 X | ||||
| Price To Sales | 4.30 X | ||||
| Revenue | 60.12 B | ||||
| Gross Profit | 42.7 B | ||||
| EBITDA | 12.33 B | ||||
| Net Income | 365 M | ||||
| Cash And Equivalents | 7 B | ||||
| Cash Per Share | 2.76 X | ||||
| Total Debt | 1.37 B | ||||
| Debt To Equity | 1.16 % | ||||
| Book Value Per Share | 15.24 X | ||||
| Cash Flow From Operations | 13.01 B | ||||
| Earnings Per Share | 1.22 X | ||||
| Total Asset | 106.67 B | ||||
| Retained Earnings | 53.9 B | ||||
About Merck Performance
By examining Merck's fundamental ratios, stakeholders can obtain critical insights into Merck's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Merck is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. MERCK INC operates under Drug ManufacturersGeneral classification in Japan and is traded on IOB. It employs 73000 people.Things to note about Merck Company performance evaluation
Checking the ongoing alerts about Merck for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Merck Company help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Merck Company had very high historical volatility over the last 90 days | |
| Over 78.0% of the company shares are owned by institutions such as pension funds | |
| Latest headline from news.google.com: Eagle Rock Investment Company LLC Sells 13,523 Shares of Merck Co., Inc. - MarketBeat |
- Analyzing Merck's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Merck's stock is overvalued or undervalued compared to its peers.
- Examining Merck's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Merck's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Merck's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Merck's stock. These opinions can provide insight into Merck's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.